The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis

Journal of Clinical Virology

Volumn 16, Issue 1, 2000, Pages 17-24

  Horváth, Radek ^a   Černý, Jan ^a   Benedík Jr , Jaroslav ^a   Hökl, Jan ^a   Jelínková, Ivana ^a   Benedík, Jaroslav ^a  

^a Centre for Cardiovascular Surgery and Transplantation   (Czech Republic)

Author keywords

Atherosclerosis; DNA; Epstein Barr virus; Human cytomegalovirus; Human herpes virus 6; Polymerase chain reaction

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA DETERMINATION; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOASSAY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VEIN WALL;

AORTA; CELL LINE; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HERPESVIRUS 6, HUMAN; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; POLYMERASE CHAIN REACTION; VEINS;

EID: 0343750708     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(99)00064-5     Document Type: Article

References (30)

1. Alcami J., Barzu T., Michelson S. Induction of an endothelial cell growth factor by human cytomegalovirus infection of fibroblasts. J. Gen. Virol. 72:1991;2765-2770.
2. Andel M., Kraml P., Dlouhý P., Málková J., Hajer J. Pathogenesis of atherosclerosis: from metabolic changes to persistent infection with aspects of cummulating disease. Praktický lékar. 77/6:1997;266-275. (in Czech).
3. Bruggeman C.A., van Dam-Mieras M.C. The possible role of CMV in atherogenesis. Prog. Med. Virol. 38:1991;1-26.
4. Danesh J., Collins R., Petro R. Chronic infections and coronary heart disease: is there a link? Lancet. 350:1997;430-436.
5. Eerdmans P.H., Persoons M.C., Debets S.J., Struijker B.H.A., Smith J.F., Bruggeman C.A., De Mey J.G. Impaired arterial reactivity following cytomegalovirus infection in the immunosupressed rat. Br. J. Pharmacol. 119:1996;637-646.
6. Grattan M.T. et al. Cytomegalovirus is asociated with cardiac allograft rejection and atherosclerosis. JAMA. 261:1989;3561.
7. Hayden MR, Reidy M. Many roads lead to atheroma, Nature Med. 1995;22-23.
8. Hendrix M.G., Dormans P.H., Kitslaar P., Bosman F., Bruggeman C.A. The presence of cytomegalovirus nucleic acids in arterial wals of atherosclerotic and non-atherosclerotic patients. Am. J. Pathol. 134:1989;1151-1157.
9. Herbein G., Strasswimmer J., Altieri M., Woehl-Jaegle M.-L., Wolf P., Obert G. Longitudial study of human herpesvirus 6 infection in organ transplantant recipients. Clin. Infect. Dis. 22:1996;171-173.
10. Jäkel K.T., Löning T., Arndt R., Rödriger W. Rejection, herpesvirus infection, and Ki-67 expression in endomyocardial biopsy specimens from heart transplant recipients. Path. Res. Pract. 188:1992;27-36.
11. Krylov A.A., Kupchinski R.A. Atherosclerosis and chronic persistent viral infection. Vrach Delo. 11:1990;43-46.
12. Kupchinski R.A. Evidence of cause-effect relationship between Epstein-Barr virus and atherosclerosis. Kardiologiia. 33:1993;66-70.
13. Kupchinski R.A., Krylov A.A. Epstein-Barr virus and other herpes viruses and pathogenesis of atherosclerosis and its complications. Kardiologia. 33:1993;56-59.
14. Lautenschlager I., Höckerstedt K., Jalanko H., Loginov R., Salmela K., Taskinen E., Ahonen J. Persistent cytomegalovirus in liver allografts with chronic rejestion. Hepatology. 25:1997;190-194.
15. Melnick J.L., Adam E., DeBakey M.E. Cytomegalovirus and atherosclerosis. Arch. Imm. Ther. Exp. 44:1996;279-302.
16. Melnick J.L., Adam E., DeBakey M.E. Possible role of cytomegalovirus in atherogenesis. JAMA. 263:1990;2204-2207.
17. Melnick J.L., Petrie B.L., Dreesman G.R., Burek J., McCollum C.H., DeBakey M.E. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 2:1983;644-647.
18. Musiani M., Zerbini M.L., Muscari A., Puddu G.M., Gentilomi G., Gibellini D. et al. Antibody patterns against cytomegalovirus and Epstein-Barr virus in human atherosclerosis. Microbiologica. 13(1):1990;35-41.
19. Nieminen MS, Mattila K, Valtonen V. Infection and inflammation as risk factors for myocardial infarction, Eur. Heart J. 1993;Suppl K:12-16.
20. Njenga M.K., Dangler C.A. Intimal lipid accretion and elevated serum cholesterol in Marek's disease virus-inoculated chickens. Vet. Pathol. 323:1995;403-411.
21. Robertson A.L., Katsura Y., Stein R.J. Viral genomes and arterial disease. Ann. Am. Acad. Sci. 148:1995;57-72.
22. Shih J.C., Kelemen D.W., Landers S.C. Culture characterization and viral infection of aortic smooth muscle cells from Japanese quail susceptible to atherosclerosis. Exp. Mol. Pathol. 61:1994;191-202.
23. Shih J.C., Kelemen D.W. Possible role of viruses in atherosclerosis. Adv. Exp. Med. Biol. 369:1995;89-98.
24. Span A.H., Grauls G., Bosman F., van Boven C.P., Bruggeman C.A. Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis. 93:1992;41-52.
25. Stites D.P., Terr A.I. Basic and Clinical Immunology. 1991;Victoria Publishing, Praha.
26. Straus S.E. Epstein-Barr virus infections. Ann. Int. Med. 118:1993;45-58.
27. Tanaka S., Toh Y., Mori R., Komori K., Okadome K., Sugimachi K. Possible role of cytomegalovirus in the pathogenesis of inflamatory aortic diseases. J. Vasc. Surg. 16:1992;274-279.
28. The TH, van den Ploeg AP, van den Berg AM, Vlieger M, van der Giessen, van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes, Transplantation 1992;54:193-198.
29. Wolff C., Skouropoulos M., Hörnschemeyer D., Wolff D., Körner M., Hufert F., Köufer R., Klessiek K. Significance of human cytomegalovirus DNA detection in immunocompromised heart transplant patients. Transplantation. 61:1996;750-757.
30. Zhou Y.F., Leon B.M., Waclawiw M.A., Popma J.J., Yu Z.X., Finkel T., Epstein S.E. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. New. Engl. J. Med. 9:1996;624-630.